Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Understanding migraines better with AI

Dagny Holle-Lee • 20 May 2020
EAN 2020
Headache Antibodies

Dagny Holle-Lee, MD, PhD, Essen University Hospital, Essen, Germany, discusses what is coming up in the migraine space and how artificial intelligence (AI) may help understand migraines better. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Dagny Holle-Lee

Migraine: CGRP mAbs efficacy measured over time
1:30
Migraine: CGRP mAbs efficacy measured over time
Dagny Holle-Lee • 20 May 2020
Efficacy of galcanezumab in older patients with migraine
0:59
Efficacy of galcanezumab in older patients with migraine
Dagny Holle-Lee • 20 May 2020

Related Videos

PACAP-38 is increased in the tear fluid of patients with migraine
1:50
PACAP-38 is increased in the tear fluid of patients with migraine
Marina Romozzi • 27 Jun 2026
TRIPLE study: triple combination therapy for chronic migraine
2:41
TRIPLE study: triple combination therapy for chronic migraine
Marina Romozzi • 27 Jun 2026
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
8:49
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
Richard Lipton • 1 Jul 2026
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
5:05
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
Richard Lipton • 1 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals